Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing HIV with limited medical resources

G J Stewart1, C Kunanusont, P Phanuphak

  • 1Department of Clinical Immunology and Allergy, Westmead Hospital, Sydney, NSW.

The Medical Journal of Australia
|November 4, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thai adaptation and reliability of three versions of the Barratt Impulsiveness Scale (BIS 11, BIS-15, and BIS-Brief).

Psychiatry research·2019
Same author

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.

Data in brief·2017
Same author

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.

Journal of autoimmunity·2017
Same author

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.

Genes and immunity·2016
Same author

Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases.

Genes and immunity·2016
Same author

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.

Clinical pharmacology and therapeutics·2015
Same journal

Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress.

The Medical journal of Australia·2026
Same journal

Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study.

The Medical journal of Australia·2026
Same journal

Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.

The Medical journal of Australia·2026
Same journal

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

The Medical journal of Australia·2026
Same journal

Striving for Racial Equity in Oral Cancer Research: A Case Study.

The Medical journal of Australia·2026
Same journal

Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

The Medical journal of Australia·2026
See all related articles

Many individuals with HIV won't access advanced treatments. Strategic resource allocation is crucial for countries to maximize care, even with limited funds, improving quality of life and end-of-life support.

Area of Science:

  • Global Health
  • Public Health Policy
  • Medical Ethics

Background:

  • Current advancements in Human Immunodeficiency Virus (HIV) treatment are not accessible to the majority of the global population.
  • Significant disparities exist in healthcare access and resource availability worldwide.
  • Effective planning is essential to bridge the gap between medical potential and practical implementation.

Purpose of the Study:

  • To highlight the critical need for strategic planning in HIV care delivery.
  • To emphasize the importance of optimizing healthcare resources in diverse national contexts.
  • To advocate for cost-effective interventions that improve patient outcomes and dignity.

Main Methods:

  • This study is a policy analysis and review of global HIV treatment accessibility.

Related Experiment Videos

  • It synthesizes data on resource allocation and healthcare infrastructure in various countries.
  • It examines the impact of targeted funding on patient care and suffering.

    • Main Results:

    • A small fraction of people with HIV benefit from cutting-edge medical interventions.
    • Substantial improvements in care are achievable through efficient resource management.
    • Even modest financial investments, when strategically applied, can significantly alleviate suffering and support dignified end-of-life care.

    Conclusions:

    • Equitable access to HIV treatment requires proactive and context-specific national planning.
    • Optimizing existing health resources is paramount to extending the benefits of medical progress.
    • Investing in well-planned interventions offers a high return in terms of reduced suffering and enhanced dignity for people with HIV.